DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA. J Biol Chem. 2020 Jan 10;295(2):645-656. doi: 10.1074/jbc.
People also ask
What is the function of the SAM domain?
What is the SAM domain containing proteins?
What is the binding domain of a protein?
Jul 13, 2003 · Refractive index and light scattering detectors were calibrated using lysozyme (14.3 kDa) and a 'non-SAM domain–binding' RNA oligomer that forms ...
DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA ... SAM domain-binding peptides as potential therapeutic agents ...
Jun 15, 2023 · ... SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA. Journal of Biological Chemistry, 295(2), 645–656 ...
GO:0032093. SAM domain binding. 108,266.50, 100.00 ; GO:0061793. chromatin lock complex. 18,044.42, 9.09 ; GO:1903386. negative regulation of homophilic cell ...
This ANKS3 homopolymerisation is prevented by ANKS6-ANKS3-SAM domain binding. The PKD causing Anks6p.R823W mutation prevents ANKS6 from binding to ANKS3 ...
Feb 14, 2012 · DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA. Journal of Biological Chemistry 2020, 295 (2) ...
DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA. Received for publication, November 15, 2019 Published, ...
Specific Eph receptor-cytoplasmic effector signaling mediated by SAM ...
elifesciences.org › articles
May 11, 2018 · Our study reveals that the Eph SAM domains have exquisitely specific target SAM domain-binding properties, although their overall SAM-SAM ...
Instead, we hypothesized that if indeed SAM domain binding to. EF1A1 was necessary for optimal inhibition of cell migration, then one would expect that ...